Literature DB >> 22296491

A turning point for natural product discovery--ESF-EMBO research conference: synthetic biology of antibiotic production.

Eriko Takano1, Roel A L Bovenberg, Rainer Breitling.   

Abstract

Synthetic Biology is in a critical phase of its development: it has finally reached the point where it can move from proof-of-principle studies to real-world applications. Secondary metabolite biosynthesis, especially the discovery and production of antibiotics, is a particularly relevant target area for such applications of synthetic biology. The first international conference to explore this subject was held in Spain in October 2011. In four sessions on General Synthetic Biology, Filamentous Fungal Systems, Actinomyces Systems, and Tools and Host Structures, scientists presented the most recent technological and scientific advances, and a final-day Forward Look Plenary Discussion identified future trends in the field.
© 2012 Blackwell Publishing Ltd.

Mesh:

Substances:

Year:  2012        PMID: 22296491     DOI: 10.1111/j.1365-2958.2012.07984.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  1 in total

1.  Vita activa in biotechnology: what we do with fungi and what fungi do with us.

Authors:  Martin Weinhold; Edeltraud Mast-Gerlach; Vera Meyer
Journal:  Fungal Biol Biotechnol       Date:  2017-12-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.